AAAAAA
Results:
1-14
|
Results: 14
Authors:
HERESCOLEVY U
JAVITT DC
Citation: U. Herescolevy et Dc. Javitt, THE ROLE OF N-METHYL-D-ASPARTATE (NMDA) RECEPTOR-MEDIATED NEUROTRANSMISSION IN THE PATHOPHYSIOLOGY AND THERAPEUTICS OF PSYCHIATRIC SYNDROMES, European neuropsychopharmacology, 8(2), 1998, pp. 141-152
Authors:
HERESCOLEVY U
JAVITT DC
ERMILOV M
MORDEL C
Citation: U. Herescolevy et al., GLYCINE AND D-CYCLOSERINE ADJUVANT PHARMACOTHERAPY FOR TREATMENT-RESISTANT SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 158-158
Authors:
SEGMAN RH
NEEMAN T
HERESCOLEVY U
FINKEL B
KARAGACEV L
SCHLAFMAN M
DUREVICH A
YAKIR A
LERNER A
SHELEVOY A
LERER B
Citation: Rh. Segman et al., GENETIC-FACTORS IN TARDIVE-DYSKINESIA - POSSIBLE ROLE OF THE DOPAMINETRANSPORTER, American journal of medical genetics, 81(6), 1998, pp. 477-477
Authors:
SEGMAN RH
SHAPIRA Y
KANYAS K
HIRSCHMANN S
HERESCOLEVY U
KARNI O
TURETSKY N
SHAPIRA B
SHELEVOY A
MODAI I
LERER B
Citation: Rh. Segman et al., ANGIOTENSIN-CONVERTING ENZYME POLYMORPHISM IN SCHIZOPHRENIA AND MAJORAFFECTIVE-DISORDER - POPULATION AND FAMILY-BASED ASSOCIATION STUDIES, American journal of medical genetics, 81(6), 1998, pp. 522-523
Authors:
KOHN Y
EBSTEIN RP
HERESCOLEVY U
SHAPIRA B
NEMANOV L
GRITSENKO I
AVNON M
LERER B
Citation: Y. Kohn et al., DOPAMINE D4 RECEPTOR GENE POLYMORPHISMS - RELATION TO ETHNICITY, NO ASSOCIATION WITH SCHIZOPHRENIA AND RESPONSE TO CLOZAPINE IN ISRAELI SUBJECTS, European neuropsychopharmacology, 7(1), 1997, pp. 39-43
Authors:
HERESCOLEVY U
GREENBERG D
LERER B
JAVITT DC
BROWN WA
Citation: U. Herescolevy et al., SERUM NEUROLEPTIC LEVELS DURING REDUCED DOSE FLUPHENAZINE DECANOATE MAINTENANCE THERAPY, Israel journal of psychiatry and related sciences, 34(4), 1997, pp. 281-289
Authors:
JAVITT DC
FRUSCIANTE M
HERESCOLEVY U
Citation: Dc. Javitt et al., CLINICAL AND PRECLINICAL EXPERIENCE WITH NMDA AUGMENTING AGENTS, Biological psychiatry, 41, 1997, pp. 3-3
Authors:
HERESCOLEVY U
SILIPO G
JAVITT DC
Citation: U. Herescolevy et al., GLYCINERGIC AUGMENTATION OF NMDA RECEPTOR-MEDIATED NEUROTRANSMISSION IN THE TREATMENT OF SCHIZOPHRENIA, Psychopharmacology bulletin, 32(4), 1996, pp. 731-740
Authors:
HERESCOLEVY U
JAVITT DC
ERMILOV M
MORDEL C
HOROWITZ A
KELLY D
Citation: U. Herescolevy et al., DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL OF GLYCINE ADJUVANTTHERAPY FOR TREATMENT-RESISTANT SCHIZOPHRENIA, British Journal of Psychiatry, 169(5), 1996, pp. 610-617
Authors:
HERESCOLEVY U
GREENBERG D
LERER B
DASBERG H
BROWN WA
Citation: U. Herescolevy et al., 2-YEAR TRIAL OF MAINTENANCE NEUROLEPTIC DOSE REDUCTION IN SCHIZOPHRENIC OUT-PATIENTS - PREDICTORS OF RELAPSE, Israel journal of psychiatry and related sciences, 32(4), 1995, pp. 268-275
Authors:
JAVITT DC
ZYLBERMAN I
ZUKIN SR
HERESCOLEVY U
LINDENMAYER JP
Citation: Dc. Javitt et al., AMELIORATION OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA BY GLYCINE, The American journal of psychiatry, 151(8), 1994, pp. 1234-1236
Authors:
ZUKIN SR
JAVITT DC
ZYLBERMAN I
HERESCOLEVY U
Citation: Sr. Zukin et al., GLUTAMATERGIC DYSFUNCTION IN PSYCHIATRIC-DISORDERS, Neuropsychopharmacology, 9(2), 1993, pp. 190000038-190000039
Authors:
HERESCOLEVY U
BROM D
GREENBERG D
Citation: U. Herescolevy et al., SELF-REPORTED PRESCRIBING PRACTICES FOR SCHIZOPHRENIC-PATIENTS AMONG ISRAELI PSYCHIATRISTS, Israel journal of psychiatry and related sciences, 30(3), 1993, pp. 164-174
Authors:
ZUKIN SR
NUSSENZVEIG IZ
JAVITT DC
HERESCOLEVY U
SIRCAR R
LINDENMAYER JP
Citation: Sr. Zukin et al., ARE NMDA RECEPTORS INVOLVED IN SCHIZOPHRENIA - CANDIDATE MECHANISMS AND EFFECT OF HIGH-DOSE ORAL GLYCINE, Journal of neurochemistry, 61, 1993, pp. 190000051-190000051
Risultati:
1-14
|